Researchers have discovered how TH1 and TH17 immune cells obtain access to neurons in multiple sclerosis.
ST266 produces an anti-inflammatory effect and can help preserve cells in the optic nerve, a new study reports.
Researchers have identified a possible new drug target for neuroinflammation.
